KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon-Interest IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Non-Interest IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kopin (KOPN) EBITDA (2016 - 2025)

Historic EBITDA for Kopin (KOPN) over the last 16 years, with Q3 2025 value amounting to $4.5 million.

  • Kopin's EBITDA rose 26184.97% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year increase of 8398.49%. This contributed to the annual value of -$17.2 million for FY2023, which is 2116.87% up from last year.
  • Per Kopin's latest filing, its EBITDA stood at $4.5 million for Q3 2025, which was up 26184.97% from -$5.5 million recorded in Q2 2025.
  • Kopin's EBITDA's 5-year high stood at $4.5 million during Q3 2025, with a 5-year trough of -$32.6 million in Q1 2024.
  • For the 5-year period, Kopin's EBITDA averaged around -$5.5 million, with its median value being -$4.1 million (2021).
  • As far as peak fluctuations go, Kopin's EBITDA crashed by 105493.92% in 2024, and later surged by 26184.97% in 2025.
  • Over the past 5 years, Kopin's EBITDA (Quarter) stood at -$3.6 million in 2021, then plummeted by 71.94% to -$6.2 million in 2022, then fell by 9.07% to -$6.8 million in 2023, then skyrocketed by 58.74% to -$2.8 million in 2024, then skyrocketed by 261.85% to $4.5 million in 2025.
  • Its EBITDA stands at $4.5 million for Q3 2025, versus -$5.5 million for Q2 2025 and -$3.9 million for Q1 2025.